发明名称 |
Policosanol nanoparticles |
摘要 |
The present invention provides nanoparticulate policosanol, and octacosanol formulations including these particles, as a well as methods of using the particles and formulations for treatment and prophylaxis of various diseases and conditions. |
申请公布号 |
US9034383(B2) |
申请公布日期 |
2015.05.19 |
申请号 |
US201113211132 |
申请日期 |
2011.08.16 |
申请人 |
NanoRx, Inc. |
发明人 |
Raghavan Palayakotai R. |
分类号 |
A61K31/045;A61K31/355;B82Y5/00;A61K9/14;A61K9/51 |
主分类号 |
A61K31/045 |
代理机构 |
Morgan, Lewis & Bockius LLP |
代理人 |
Morgan, Lewis & Bockius LLP |
主权项 |
1. A composition comprising nanoparticles of policosanol, wherein each nanoparticle comprises:
(a) a policosanol fraction comprising about 50% to 69% octacosanol; and (b) a stabilizer fraction comprising tocopheryl polyethylene glycol (1000) succinate (“TPGS”), wherein the ratio of octacosanol:stabilizer fraction ranges from about 1:1.6 to about 1:3.5 and the nanoparticles have a size between about 40 nm and about 100 nm in diameter and wherein at least 99% of the nanoparticles have a particle size of less than about 70 nm as determined by a light scattering method. |
地址 |
Chappaqua NY US |